United States News All stories

CareTrust REIT (NYSE:CTRE) agreed to acquire 45 U.K. care homes from LNT for about £1.1 billion, including 24 properties acquired for approximately £576 million in the first closing.

Cullinan Therapeutics (NASDAQ:CGEM) initiated an FDA New Drug Application for first-line zipalertinib plus chemotherapy after REZILIENT3 showed a 6.0-month median progression-free survival improvement.

Manulife (NYSE:MFC) completed its previously announced long-term care reinsurance transaction with Munich American Reassurance Company, covering a policy block with C$3.2 billion of reserves.

Ultragenyx (NASDAQ:RARE) announced that the European Medicines Agency validated its marketing authorisation application for investigational gene therapy rebisufligene etisparvovec to treat Sanfilippo syndrome Type A.

Summit Therapeutics (NASDAQ:SMMT) announced a clinical trial collaboration with AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo to evaluate ivonescimab with Datroway in multiple solid tumor settings, including breast and lung cancer.

Shares of major U.S. health insurers moved lower after companies including UnitedHealth Group (NYSE:UNH) and CVS Health (NYSE:CVS) subsidiary Aetna announced their Medicare Advantage plan designs for 2027.

Tesla (NASDAQ:TSLA) registrations increased across several European markets in September, extending a recent recovery in the electric vehicle maker’s regional sales performance.

Arthur J. Gallagher (NYSE:AJG) completed the acquisition of Albany Insurance Services, a New Zealand-based retail insurance brokerage serving commercial and personal insurance clients.

PolyPid (NASDAQ:PYPD) regained exclusive European commercialization rights for D-PLEX₁₀₀ after the company and ADVANZ PHARMA mutually agreed to terminate their 2022 licensing, distribution and supply agreement covering Europe.

Broadcom (NASDAQ:AVGO) has agreed to provide Anthropic with up to $42 billion in financing to support the artificial intelligence company’s infrastructure expansion, according to details from Anthropic’s IPO prospectus reported by Reuters.

Costamare (NYSE:CMRE) declared a quarterly common-stock dividend of $0.125 per share for the quarter ended September 30, 2026.

National Fuel Gas Company (NYSE:NFG) completed its acquisition of CenterPoint Energy’s Ohio natural gas utility business, Vectren Energy Delivery of Ohio, expanding its regulated utility operations.

Brookfield (NYSE:BAM) announced the final close of Oaktree’s inaugural Asset-Backed Finance Fund, with total commitments of $2 billion across the fund and related investment vehicles.

Namib Minerals (NASDAQ:NAMM) reported first-half 2026 financial results, with higher gold prices supporting revenue and operating performance despite lower production levels.

nVent Electric (NYSE:NVT) completed its acquisition of Maverick Power, a manufacturer of engineered power distribution and infrastructure solutions for data centers, for a purchase price of $1.75 billion, subject to customary adjustments.

Novo Nordisk (NYSE:NVO) presented exploratory analyses from the STEP UP program showing that Wegovy (semaglutide) was associated with reductions in liver fat among adults with obesity who did not have diabetes.

Cardinal Health (NYSE:CAH) entered into a binding letter of intent with CVS Health to extend their existing pharmaceutical distribution agreement through June 30, 2032.

Agomab (NASDAQ:AGMB) reported topline results from the STENOVA open-label extension study of ontunisertib in patients with fibrostenosing Crohn’s disease, with 49 patients completing the 48-week extension period.

Origin Agritech (NASDAQ:SEED) entered into an agreement to sell its principal corn seed production subsidiary stake as part of a transaction involving Xinjiang Originbo.

Shattuck Labs (NASDAQ:STTK) announced plans to evaluate SL-325 in a Phase 2 clinical trial for patients with moderate to severe hidradenitis suppurativa (HS), expanding the program beyond its existing inflammatory bowel disease development.

CenterPoint Energy (NYSE:CNP) completed the sale of its Ohio natural gas distribution business, Vectren Energy Delivery of Ohio, to National Fuel Gas Company for $2.62 billion.

Nebius (NASDAQ:NBIS) announced the acquisition of Inferize, an inference optimization company whose technology helps reduce the time required to launch and scale large artificial intelligence models.

Commerce Bank announced the completion of its acquisition of Nolan & Associates, a St. Louis-based investment banking firm focused on serving middle-market companies nationwide.

Eli Lilly (NYSE:LLY) reported post-hoc analyses from the Phase 3 ATTAIN-1 trial showing Foundayo was associated with lower modeled 10-year risks of type 2 diabetes and cardiovascular disease in adults with obesity or overweight.